Showing results (141-150 of 537) with videos related to
Sort By:
Pageof 54
Expert Opinion on Pharmacotherapy|March 22, 2023
Current and emerging pharmacotherapy for menstrual migraine: a narrative reviewClaire E J Ceriani, Stephen D SilbersteinHeadache|August 9, 2002
Hemicrania continua responds to cyclooxygenase-2 inhibitorsMario F P Peres, Stephen D SilbersteinHeadache|September 24, 2005
Removing barriers to appropriate migraine treatment: formulary limitations and triptan package sizeStephen D Silberstein, David Dodick, Jim KesslickBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 27, 2022
Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and RationaleFred Cohen, Hsiangkuo Yuan, Stephen D SilbersteinHandbook of Clinical Neurology|September 7, 2010
Headache attributed to non-vascular intracranial disorderHans-Christoph Diener, U Johansson, David W DodickHeadache|October 15, 2013
Sporadic hemiplegic migraine with permanent neurological deficitsTodd J Schwedt, Jiying Zhou, David W DodickHeadache|February 1, 2008
Occipital nerve stimulation for headache: mechanisms and efficacyPeter J Goadsby, Thorsten Bartsch, David W DodickJournal of the Neurological Sciences|June 25, 2013
OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baselineStephen D Silberstein, Andrew M Blumenfeld, Roger K Cady, et al.CNS Drugs|June 21, 2005
Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesisAndrew J Dowson, David W Dodick, Volker LimmrothHeadache|January 5, 2011
The effect of prophylactic medications on TMS for migraine auraAmy C Almaraz, Esma Dilli, David W DodickPageof 54